Sign in: Staff/Students
A delegation of Ethiopian academics, business leaders and diplomats visited the University to explore possible collaborations.
Ethiopian ambassador to the UK, Ambassador Berhanu Kebede; Head of Nano research at the University of Gondar, Dr Birhanu Tulu, and Ethiopia representative for NanoLandGlobal, Abiy Negussie were welcomed by Pro-Vice-Chancellor for Innovation and Partnerships, Professor Steve Holloway.
The visit was the outcome of efforts made by alumnus Dermott Reilly, CEO of NanoLandGlobal. Mr Reilly’s firm is seeking to strengthen links between the two countries.
The delegation was taken on a short tour of the University’s Micro Bio Refinery, Centre for Materials Discovery and Stephenson Institute for Renewable Energy. The visitors also received an insight into the Materials Innovation Factory, currently under construction.
You must be logged in to post a comment.
All recent news
COMET Initiative shortlisted for MRC Impact Prize
Report identifies gaps in ethnicity research in maternal care
English Language Centre: Supporting international students on campus
University retains ‘2:1 Class’ sustainability ranking in People & Planet University League
Help us improve our social media to win £50 Everyman Cinema vouchers
Congratulations to @prw_paula and the @COMETinitiative team who have been shortlisted for the #MRCImpactPrize for Open Science Impact! Read the full story ➡️http://bit.ly/3HgWq0M
We were delighted to present ten esteemed figures with honorary degrees in a special ceremony @liverpoolphil yesterday including former MP @LouiseEllman, @Everton CEO Denise Barrett-Baxendale and @TheLegItPodcast host @AndyGbootneck.
Read more here 👉https://news.liverpool.ac.uk/2022/12/06/everton-ceo-and-former-mp-receive-honorary-degrees-from-university-of-liverpool/
An off-patent liver disease drug could prevent #COVID19 infection, a new @Nature study has found.
@livuniHLS scientists played a key role in the collaborative study, which involved a unique mix of ‘mini-organs’, donor organs, animal studies & patients.